Nucleic acid vaccine for toxoplasma infection prevention and application thereof

The invention discloses a nucleic acid vaccine for toxoplasma infection prevention and application thereof. The nucleic acid vaccine uses a pVAX plasmid as a carrier, fuses a toxoplasma CDPK2 gene sequence, and has a base sequence shown as a SEQ ID NO: 1. The nucleic acid vaccine provided by the inv...

Full description

Saved in:
Bibliographic Details
Main Authors ZHU XINGQUAN, CHEN KAI, HUANG SIYANG, ZHU WEINING, WANG JINLEI
Format Patent
LanguageChinese
English
Published 09.01.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention discloses a nucleic acid vaccine for toxoplasma infection prevention and application thereof. The nucleic acid vaccine uses a pVAX plasmid as a carrier, fuses a toxoplasma CDPK2 gene sequence, and has a base sequence shown as a SEQ ID NO: 1. The nucleic acid vaccine provided by the invention has a good effect of preventing toxoplasma infection. 本发明公开了种用于弓形虫感染预防的核酸疫苗及其应用，所述核酸疫苗以pVAX质粒作为载体，融合弓形虫CDPK2基因序列，其碱基序列如SEQ ID NO:1所示。本发明所提供的核酸疫苗在预防弓形虫感染上具有良好的效果。
Bibliography:Application Number: CN20171760455